Peptide research
AOD-9604 is marketed as a fragment with weight-loss claims. Enforcement and board scrutiny often track marketing hype — conservative federal and state posture is common.
PeptSense tracks AOD-9604 across federal 503A Bulks List chain steps, PCAC advisory context, and state board positions. Status is never inferred from forums or marketing sites — only published citations with effective dates.
Latest published federal event for 503A compounding pharmacies. Sign in for your licensed states and facility type.
UnclearNot a legal determination. Replace placeholder citations during curation.
Get federal + state lanes, chain steps, printable answer cards, and compliance documents for the states you license in.